Peritoneal Neoplasms
📧 Sign up to get email alerts when something new happens for Peritoneal Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-07EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorises a biosimilar version of bevacizumab (Abevmy) for multiple cancer indications, expanding access to this biologic therapy.
-
EMA approval · 2026-06-10EMA Authorised: Zejula (niraparib (tosilate monohydrate)) — GlaxoSmithKline Trading Services Limited
The EMA authorised Zejula (niraparib tosilate monohydrate) for ovarian, fallopian tube, and peritoneal neoplasms, under GlaxoSmithKline Trad…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy [NA]
A clinical trial is evaluating intraoperative 20% albumin with Ringer lactate versus Ringer lactate alone during cytoreductive surgery with …
-
EMA approval · 2025-11-26EMA Authorised: Zejula (niraparib (tosilate monohydrate)) — GlaxoSmithKline Trading Services Limited
The EMA authorised Zejula for fallopian tube neoplasms, peritoneal neoplasms, and ovarian neoplasms. GlaxoSmithKline Trading Services Limite…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) [Phase 3]
A Phase 3 trial evaluating pembrolizumab followed by maintenance olaparib with first-line chemotherapy in BRCA non-mutated advanced epitheli…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a PARP inhibitor combined with a CTLA-4 blocker in BRCA-deficient ovarian cancer, including fallopian tu…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing atezolizumab plus paclitaxel, carboplatin, and bevacizumab versus control in newly diagnosed ovarian, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - [Phase 2]
Phase 2 trial update on pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A clinical trial evaluating topotecan in combination with gefitinib (Iressa) for ovarian, peritoneal, or fallopian tube cancers has complete…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing patupilone to doxorubicin in ovarian, fallopian tube, or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-05Clinical Trial Update: Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis [Phase 3]
Phase 3 trial evaluating lanreotide microparticles for palliative treatment in peritoneal carcinomatosis; completed study assessing efficacy…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") [Phase 2]
Phase 2 trial comparing standard chemotherapy plus enzastaurin versus placebo in ovarian cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: PIPAC for Peritoneal Metastases of Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for PIPAC (pressurized intraperitoneal aerosol chemotherapy) in peritoneal metastases from colorectal cancer, …
-
EMA withdrawal · 2017-11-10EMA Application withdrawn: Kyomarc (bevacizumab) — Amgen Europe B.V.
The EMA withdrew the application for Kyomarc (bevacizumab) from Amgen Europe B.V., relating to several carcinomas and neoplasms.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Pharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal Cancers [Phase 1]
Phase 1 trial evaluating the pharmacokinetics, safety, and preliminary efficacy of a nanoparticle paclitaxel in patients with peritoneal neo…
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [Phase 1]
Phase 1 trial assessing continuous hyperthermic peritoneal perfusion with cisplatin in children with peritoneal cancers. The study status is…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy [Phase 2]
A Phase 2 study evaluating MORAb-003 (farletuzumab) for women with ovarian cancer that relapsed after platinum-based chemotherapy has comple…
-
CLINICAL_TRIALS research · 2011-02-25Clinical Trial Update: Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire [Phase 2]
Phase 2 clinical trial validating a French version of the FACT-GOG/NTX questionnaire for peripheral neurotoxicity in ovarian and related can…
-
CLINICAL_TRIALS trial_result · 2006-10-02Clinical Trial Update: Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating ACA 125 in patients with ovarian cancer, focusing on safety and immune response.